Co-Diagnostics, Inc. Soared
Thu, Jun 06, 2024 at 07:32 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) rocketted at $1.43, representing a gain of 38.8%. On Thu, Jun 06, 2024, CODX:NASDAQ hit a New 2-Week High of $1.43. The stock appeared on our News Catalysts scanner on Mon, May 13, 2024 at 10:31 AM in the 'EARNINGS' category. From Thu, May 23, 2024, the stock recorded 33.33% Up Days and 20.00% Green Days
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- Virax Biolabs Group Limited (VRAX:NASDAQ), 85.85%
- FibroBiologics Inc. (FBLG:NASDAQ), 53.88%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Logistic Properties of the Americas (LPA:NYSEMKT), 48.99%
- GameStop Corp. (GME:NYSE), 47.45%
- Tungray Technologies Inc (TRSG:NASDAQ), 43.33%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 42.25%
- Leafly Holdings Inc. (LFLY:NASDAQ), 39.31%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 38.84%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 30.6%